u/camila_vasquez

Not to be pedantic but SURPASS and TRIUMPH are being used interchangeably and they are not interchangeable in real life.

always state your country, advice from another jurisdiction can harm you

glycaemic control first, that is the original indication

Adding to this: metformin is doing more work than the comment implies.

insulin and sulfonylurea interactions are real hypo risk

type 2 is the indication, weight loss is the side effect

Small correction: the trial was 12 weeks, not 35. Does not change your point but people will quote it.

type 2 is the indication, weight loss is the side effect

number-needed-to-treat is the house dialect

denial reason codes matter, ask for the actual code

That is net peptide content, not purity. Different number, different meaning.

No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.

Which country? Rules vary.

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

absolute risk reduction, not relative risk reduction, that is how you decide

the Spain import rules are specific to Spain

I am going to push back on this slightly.

A1c, CGM, stacking with metformin

resubmission after denial requires new documentation